Grace and Braskem Sign Multi-Year Agreement
News Jul 10, 2012
W. R. Grace & Co. has announced that it has signed a multi-year agreement with Braskem to develop process technologies and catalyst solutions to produce green chemicals.
The agreement is intended to advance the commercialization of a process to convert renewably sourced feedstocks into value-added products.
Grace is a global supplier of innovative catalyst technologies with a leading position in the petroleum refining and polyolefin market segments.
Braskem is the leading thermoplastics resin producer in the Americas, with a goal of becoming the world leader in sustainable chemistry by 2020. Details and financial terms of the agreement were not disclosed.
The use of renewable feedstocks is a growing trend in the global chemical industry.
The technology under development in the Grace-Braskem collaboration is based on carbon sources from renewable agricultural processes that contribute to lower carbon emissions than traditional feedstocks.
“We are pleased to have the opportunity to work in cooperation with the world leader in green plastics,” said George Young, Vice President of New Business Development at Grace.
Young continued, “This collaboration demonstrates our commitment to become a leading supplier of catalysts to the renewable chemicals industry.”
Braskem is a global leading producer of biopolymers and has announced plans to expand production of sugar-based bio-polyolefins.
“We continue to innovate to meet market needs for more sustainable solutions,” said Edmundo Aires, Vice President of Corporate Innovation and Technology at Braskem. “We’re convinced this partnership will enable us to do this better.”
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018